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As part of  a program to develop synthetic helix–linker–helix peptides the conformational properties of
various linking segments are currently being investigated. The propensity of  á,á-di-n-propylglycine (Dpg)
residues to adopt backbone conformations in the extended region of  the Ramachandran map, suggested
by theoretical calculations and supported by experimental observations, prompted us to investigate the
utility of  the Gly-Dpg-Gly segment as a rigid linking motif. The crystal structure of  the achiral tripeptide
Boc-Gly-Dpg-Gly-OH 1 revealed a fully extended conformation (ö = ±1788, ø = ±1718) at Dpg(2), with
Gly(1) adopting a helical conformation (ö = 12728, ø = 12328). The addition of  flanking helical segments in
the 14 residue peptide Boc-Val-Val-Ala-Leu-Gly-Dpg-Gly-Val-Ala-Leu-Aib-Val-Ala-Leu-OMe 2 resulted
in the crystallographic characterization of  a continuous helix over the entire length of  the peptide. Peptide
1 crystallized in the centrosymmetric space group P21/c with a = 9.505(2) Å, b = 11.025(2) Å, c = 20.075(4)
Å, â = 90.198 and Z = 4. Peptide 2 crystallized in space group P212121 with a = 10.172(1) Å, b = 17.521(4) Å,
c = 46.438(12) Å and Z = 4. A comparative analysis of  Gly-Dpg-Gly segments from available crystal
structures indicates a high conformational variability of  this segment. This analysis suggests that context
and environment may be strong conformational determinants for the Gly-Dpg-Gly segment.
Introduction
The ability to construct stereochemically well-defined peptide
helices, using a-aminoisobutyric acid (Aib) and related a,a-
dialkylated glycines,1–6 has stimulated attempts to assemble
helix–linker–helix motifs as models for super secondary struc-
tures in proteins.7 The use of nonhelical linkers should facilitate
the design of molecules with distinct helical segments. A close
packed, approximately antiparallel helix arrangement may then
be achieved as a consequence of solvophobic effects, in which
release of solvent molecules entropically drives the association
of large complementary molecular surfaces.8–10. In the ‘Mec-
cano set’ approach being developed in this laboratory, various
linking segments are being investigated. Earlier reports have
described attempts to use Gly-Pro units,11, -amino acids 12 and
e-aminocaproic acid (Acp) 13 as linking units between helix pairs.
In this paper we describe an analysis of the linking segment
Gly-Dpg-Gly (Dpg = a,a-di-n-propylglycine). The choice of
Dpg was stimulated by a report that higher a,a-di-n-alkyl-
glycines have pronounced energy minima in the fully extended
(f, y ≈1808) region of conformational space,14,15 suggesting the
utility of this residue in designing stereochemically rigid non-
helical segments. Interestingly, while early crystal structure
analyses of homo-oligopeptides containing Dpg provided evi-
dence for the occurrence of the fully extended conform-
ations,16,17 many subsequent reports provided examples of Dpg
in helical conformations.6,18. Both theoretical and experimental
studies suggest that two distinct regions of conformational
Fig. 1 A stereoview of the tripeptide Boc-Gly-Dpg-Gly-OH 1 structure
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Table 1 Crystal data and structure refinement details for peptide 1 and 2 
 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
 
 
 
 
 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(000) 
Crystal size 
q range for data collection 
Index ranges 
 
 
Independent reflections 
Reflections [I > 2s(I)] 
Data/restraints/parameters 
Goodness-of-fit 
Final R indices [I > 2s(I)] 
 
R indices (all data) 
 
Largest difference peak and hole 
Peptide 1 
C17H31N3O6 
373.45 
293(2) K 
1.541 80 Å
Monoclinic 
P21 /c 
a = 9.505(2) Å 
b = 11.025(2) Å 
c = 20.075(4) Å 
a = 908 
b = 90.198 
g = 908 
2103.7(7) Å3 
4 
1.179 Mg m23 
0.740 mm21 
808 
0.4 × 0.4 × 0.4 mm 
4.40–74.988 
211 < h < 11 
0 < k < 13 
0 < l < 25 
4323 
3409 
4323/0/265 
0.959 
R1 = 0.0460 
wR2 = 0.1350 
R1 = 0.0572 
wR2 = 0.1468 
0.242 and 20.288 e Å23 
Peptide 2 
C70H124N14O19 
1465.83 
293(2) K 
1.541 80 Å 
Orthorhombic 
P212121 
a = 10.172(1) Å 
b = 17.521(4) Å 
c = 46.438(12) Å 
a = 908 
b = 908 
g = 908 
8276(3) Å3 
4 
1.176 Mg m23 
0.704 mm21 
3176 
0.8 × 0.5 × 0.2 mm 
1.90–75.218 
0 < h < 12 
0 < k < 21 
0 < l < 58 
9428 
7231 
9428/0/1052 
1.312 
R1 = 0.0557 
wR2 = 0.1569 
R1 = 0.0711 
wR2 = 0.1671 
0.468 and 20.240 e Å23 
Table 2 Backbone dihedral angles for the Gly-Dpg-Gly segment in peptide crystal structures 
Residue 
Gly 
 
 
Dpg g 
 
 
Gly 
 
Dihedral angles/8 a 
f 
y 
f 
y 
f
y 
Segment 1 b 
272 
232 
 
178 
171 
 
263 
 
Segment 2 c 
266 
251 
 
252 
244 
263 
234 
Segment 3 d 
294, 296 f 
2162, 2153 
 
253, 256 
250, 247 
 
264, 265 
236, 240 
Segment 4 e 
72 
2166 
 
254 
246 
 
2 78 
29 
Segment 5 
280 
218 
 
56 
32 
 
85
23 
a Dihedral angle nomenclature follows that described in ref. 29. b Boc-Gly-Dpg-Gly-OH (this study). c Boc-Val-Val-Ala-Leu-Gly-Dpg-Gly-Val-Ala-
Leu-Aib-Val-Ala-Leu-OMe (this study). d Boc-Gly-Dpg-Gly-Val-Ala-Leu-Aib-Val-Ala-Leu-OMe (ref. 27). e Boc-Gly-Dpg-Gly-Gly-Dpg-Gly-
NHMe. Segment 4 is the N-terminus tripeptide and segment 5 corresponds to the C-terminus tripeptide (ref. 28). f Two values correspond to the two
conformers present in the crystallographic asymmetric unit. g The Dpg sidechain torsion angles in peptide 1 (this study) are c1 (2578, 568), c2 (1708,
1708). 
space (fully extended and helical) are energetically accessible to
Dpg residues. The sequence context and environmental influ-
ences presumably determine the precise nature of the conform-
ation adopted. The use of Gly-Dpg-Gly in the present study
was dictated by the fact that Gly is highly conformationally
flexible and has a relatively low helix propensity. We describe in
this report crystal structures of a tripeptide Boc-Gly-Dpg-Gly-
OH (peptide 1) and a 14 residue peptide Boc-Val-Val-Ala-Leu-
Gly-Dpg-Gly-Val-Ala-Leu-Aib-Val-Ala-Leu-OMe (peptide 2).
While the Dpg residue adopts a fully extended conformation in
the former, a continuous helix is obtained in the latter. Compar-
isons with other crystallographically determined Gly-Dpg-Gly
segments reveals a significant degree of conformational vari-
ability in the sequence.
Experimental
Peptides were synthesized by conventional solution phase
procedures 19 and purified by medium pressure liquid chrom-
atography on a reverse phase C18 (40–60 m) column using
methanol–water gradients. Peptides were checked for homo-
geneity by high performance liquid chromatography on a
Table 3 Torsion Angles a (8) in Boc-Val-Val-Ala-Leu-Gly-Dpg-Gly-
Val-Ala-Leu-Aib-Val-Ala-Leu OMe (peptide 2) 
Residue 
Val (1) 
Val (2) 
Ala (3) 
Leu (4) 
Gly (5) 
Dpg (6) 
Gly (7) 
Val (8) 
Ala (9) 
Leu (10) 
Aib (11) 
Val (12) 
Ala (13) 
Leu (14) 
f 
261 b 
255 
261 
268 
266 
252 
263 
263 
262 
260 
256 
278 
2106 
294 
y 
223 
242 
238 
239 
251 
244 
234 
245 
240 
251 
244 
210 
26 
177 c 
w 
175 
180 
179 
180 
173 
2176 
177 
178 
176 
2169 
2172 
2178 
2179 
2176 d 
c1 
264, 63 
270, 167 
 
260 
 
269, 170 
 
268, 167 
 
176 
 
67, 259 
 
277 
c2 
 
 
 
264, 173 
 
178, 2178 
 
 
 
66, 2171 
 
 
 
250, 2178 
a The torsion angles for rotation about bonds of the peptide backbone
(f, f, and w) and about bonds of the amino acid side-chains (c1, c2) as
suggested by the IUPAC-IUB Commission on Biochemical Nomen-
clature (ref. 29). Estimated standard deviations ~1.08. b C9(0)–N(1)–
Ca(1)–C9(1). c N(14)–Ca(14)–C9(14)–O(OMe). d Ca(14)–C9(14)–
O(OMe)–C(OMe). 
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Table 4 Potential hydrogen bond parameters in Boc-Val-Val-Ala-Leu-Gly-Dpg-Gly-Val-Ala-Leu-Aib-Val-Ala-Leu-OMe 
  Bond length/Å Bond angle/8 
Type 
Intermolecular 
 
 
Intramolecular 
4 → 1 b 
4 → 1 b 
4 → 1 
4 → 1 
4 → 1 
4 → 1 c 
4 → 1 
4 → 1 
4 → 1 
4 → 1 
4 → 1 b 
4 → 1 
 
5 → 1 
5 → 1 b 
5 → 1 b 
5 → 1 b 
5 → 1 b 
5 → 1 c 
5 → 1 b 
5 → 1 b 
5 → 1 c 
5 → 1 
5 → 1 c 
 
Solvent-peptide 
Donor 
 
O(W) 
N(1) 
N(2) 
 
 
N(3) 
N(4) 
N(5) 
N(6) 
N(7) 
N(8) 
N(9) 
N(10) 
N(11) 
N(12) 
N(13) 
N(14) 
 
N(4) 
N(5) 
N(6) 
N(7) 
N(8) 
N(9) 
N(10) 
N(11) 
N(12) 
N(13) 
N(14) 
 
O(M) d 
Acceptor 
 
O(13) 
O(W) a 
O(W) a 
 
 
O(0) 
O(1) 
O(2) 
O(3) 
O(4) 
O(5) 
O(6) 
O(7) 
O(8) 
O(9) 
O(10) 
O(11) 
 
O(0) 
O(1) 
O(2) 
O(3) 
O(4) 
O(5) 
O(6) 
O(7) 
O(8) 
O(9) 
O(10) 
 
O(3) 
N ? ? ? O 
 
2.83 
3.14 
3.04 
 
 
3.01 
3.01 
3.20 
3.76 
3.19 
3.18 
3.23 
3.35 
3.32 
3.70 
3.02 
3.54 
 
3.79 
2.96 
3.0 
2.94 
2.92 
3.48 
3.04 
2.86 
3.38 
3.67 
3.20 
 
2.88 
H ? ? ? O 
 
 
 
 
 
2.33 
2.50 
2.71 
3.51 
2.81 
2.57 
2.78 
2.98 
2.84 
3.11 
2.23 
2.71 
 
3.00 
2.16 
2.20 
2.19 
2.20 
2.63 
2.21 
2.06 
2.57 
3.12 
2.69 
 
 
C]]O ? ? ? H 
 
 
 
 
 
123 
100 
92 
85 
84 
100 
104 
86 
91 
96 
112 
102 
 
141 
157 
161 
132 
146 
153 
156 
146 
149 
135 
135 
 
 
C]]O ? ? ? N 
 
 
 
 
 
130 
114 
105 
97 
99 
111 
116 
99 
103 
105 
121 
106 
 
141 
164 
160 
142 
153 
155 
160 
152 
152 
145 
169 
 
 
O ? ? ? HN 
 
 
 
 
 
137 
119 
117 
100 
109 
129 
114 
109 
117 
128 
152 
163 
 
155 
156 
172 
145 
143 
167 
164 
154 
158 
124 
119 
 
 
a Symmetrically related by the relation (2x 1 ¹¯
²
, 2y 1 1, z 1 ¹¯
²
). b These are the acceptable hydrogen bonds satisfying the criteria of hydrogen bond
geometry (ref. 24). c These are the weak hydrogen bonds (ref. 24). d Oxygen atom of CH3OH. 
Fig. 2 Packing diagram for Boc-Gly-Dpg-Gly-OH 1. The inter-
molecular hydrogen bonds [O(1) ? ? ? N(3)[2x, 0.5 1 y, 0.5 2 z] = 2.84
Å, O(2) ? ? ? N(1)[2x 1 1, 2y, 2z] = 2.98 Å, O(3) ? ? ? O(L)[2x 1 1,
2y 1 1, 2z] = 2.62 Å] are indicated by broken lines.
reversed phase C18 (5 m) column and characterized by 400 MHz
1H NMR spectroscopy. Peptide 2 was obtained as a deletion
sequence in the synthesis of a longer symmetrical seventeen
residue peptide.
Crystals of peptide 1 and 2 were obtained by slow evapor-
ation from a methanol–water solution. X-Ray diffraction data
for both the peptide crystals were collected at room temp-
erature, 21 8C, with an automated four-circle diffractometer
using Cu-Ka (l = 1.5418 Å) radiation. 25 reflections in the
108 < q < 158 range were used for determining the cell con-
stants in both cases. Though the b value (90.198) is close to 908
in the case of peptide 1, the significant difference between
hkl and the corresponding h¯kl reflections suggests a monoclinic
cell. In the case of peptide 1 the structure was determined by
the direct phase determination method.20 The structure of pep-
tide 2 was obtained by the vector search method 21 followed by
partial structure expansion.22 The helical backbone fragment
(residue 2 to residue 8) of the sequence Boc-Aib-Val-Ala-Leu-
Aib-Val-Ala-Leu-Aib-OMe 23 was used in the search method.
Both the peptide structures were refined isotropically followed
by anisotropic least-squares refinement. Hydrogen atoms were
added geometrically and allowed to ride with the corresponding
heavy atoms in the final cycle of the refinement. All the relevant
crystallographic data collection parameters and structure
refinement details for the two peptides are summarized in Table
1.†
† Atomic coordinates, bond lengths and angles, and thermal param-
eters have been deposited at the Cambridge Crystallographic Data
Centre (CCDC). For details of the deposition scheme, see ‘Instructions
for Authors’, J. Chem. Soc., Perkin Trans. 2, 1997, Issue 1. Any request
to the CCDC for this material should quote the full literature citation
and the reference number 188/80.
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Fig. 3 Stereoview of the crystal structure of peptide 2. The Gly-Dpg-Gly segment is indicated in bold type. The intramolecular hydrogen bonds are
indicated by broken lines (see Table 4).
Results and discussion
Extended Dpg residue in peptide 1
Fig. 1 shows a stereoview of the molecular conformation of
tripeptide 1 in crystals. The backbone conformational angles
are listed in Table 2, which also provides a comparison with
structures of the same segment in larger peptides. In tripeptide
1 the Dpg residue adopts a fully extended conformation while
Gly(1) lies in the helical region. The achiral peptide crystallizes
in a centrosymmetric space group, with molecules of both
helical senses being present in the unit cell. The molecules are
held in the crystal by intermolecular hydrogen bonds formed
between symmetry related molecules (Fig. 2). Surprisingly,
several hydrogen bond donor and acceptor groups do not
participate in hydrogen bonding interactions.
The peptide helix in the 14 residue peptide 2
Fig. 3 shows a stereoview of the conformation of the 14 residue
peptide determined in crystals. The backbone and side-chain
torsion angles are listed in Table 3. Intramolecular and inter-
molecular hydrogen bonds are summarized in Table 4. Hydro-
gen bond parameters are listed for all potential 4 → 1 and
5 → 1 interactions to provide a ready assessment of helix
type. This assumes importance in view of the fact that in helical
peptides assignment of 310 and a-helical structures is not always
readily apparent.24 The molecule forms an almost completely
a-helical structure, stabilized by successive 5 → 1 hydrogen
bonds. As frequently observed in peptide helices there is a 310-
helical turn at the N-terminus with a 4 → 1 hydrogen bond
between the Boc(0)CO and Ala(3)NH groups . A single 310-
helical hydrogen bond is also observed near the C-terminus
between Leu(10)CO and Ala(13)NH groups. In the centre of
the helix there is a evidence of a possible transition between
a and 310-helical structures. Gly(5)CO appears to be involved
in a 4 → 1 interaction with Val(8)NH, while a correspond-
ing 5 → 1 interaction with Ala(9)NH is definitely weaker as
indicated by the N ? ? ? O distances. The molecules pack in the
crystal as columns of antiparallel helices, held together in each
column by head-to-tail hydrogen bonds mediated by a single
bridging water molecule (Fig. 4). A lone methanol molecule is
trapped between helical columns and forms a single hydrogen
bond with the CO group of Ala(3). This is a relatively rare
example of solvation involving bifurcated hydrogen bond form-
ation to a CO group involved in a strong intrahelical hydro-
gen bond. Such solvent interactions are also observed in protein
structures.25 The CH3 group of the CH3OH molecule is in close
van der Waals contact with the hydrophobic side chains of
Ala(3), Dpg(6), Leu(4) [21 1 x,y,z], Val(8) [21 1 x,y,z], and
Aib(9) [1 2 x, ¹¯
²
1 y, ¹¯
²
2 z] residues (Fig. 5). Such trapped alco-
hol molecules in helical clusters have also been observed earlier
in structures of hydrophobic helices.26
Context dependent Gly-Dpg-Gly conformation
Fig. 6 shows an overlay of the structures of the 14 residue
peptide 2 and the helical decapeptide Boc-Gly-Dpg-Gly-Val-
Ala-Leu-Aib-Val-Ala-Leu-OMe.27 Residues 5–14 of peptide 2
are exactly identical in sequence to the decapeptide. Com-
parison of the dihedral angles in Table 2 together with Fig. 6
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establishes that the Gly-Dpg-Gly segment switches to a com-
pletely helical conformation in peptide 2, whereas a nonhelical
N-terminus is observed in the decapeptide. Interestingly, Table
2 shows that the 14 residue peptide 2 is the only example where
the Gly-Dpg-Gly segment adopts a completely helical con-
formation. In four out of five peptides listed in Table 2 the Dpg
residue adopts helical f, y values, with peptide 1 being the sole
exception. However, the overall conformation of the tripeptide
segment is nonhelical in all the cases with the exception of pep-
tide 2. In two examples Gly(1) adopts a semi-extended con-
Fig. 4 Packing diagram for the 14-residue peptide 2. View down the
crystallographic x-axis. Intermolecular hydrogen bonds are indicated
by broken lines. W indicates the oxygen molecule of the water and M
represents the trapped methanol molecule.
Fig. 5 The van der Waals environment of the methanol molecule (M).
Atoms which lie within ~4 Å are indicated by the dotted lines. The bold
broken line indicates the hydrogen bond between the oxygen atom of
methanol and the Ala(3)CO group.
formation. The peptide Gly-Dpg-Gly-Gly-Dpg-Gly-NHMe
provides an interesting example of a multiple b-turn structure.
The N-terminus Gly-Dpg-Gly segment exhibits a type-II (II9)
b-turn conformation with Gly(1) and Dpg(2) occupying the
i 1 1 and i 1 2 positions. The C-terminus Gly-Dpg-Gly seg-
ment forms a type-I (I9) b-turn centred at Dpg(5) and Gly(6).
While Gly(4) and Dpg(5) adopt helical f, y values, the signs of
the dihedral angles are opposite, indicative of opposing helix
senses.28
The above comparison of the Gly-Dpg-Gly conformation in
peptides of varying length and sequence suggests that the con-
formation of this segment may be modulated by subtle
environmental effects. Although Dpg residues are constrained
to adopt helical or fully extended conformations, the com-
bination of these two stereochemical alternatives with f, y
variations at the flanking Gly residues leads to appreciable
conformational diversity. Somewhat disappointingly, the Gly-
Dpg-Gly segment in the 14-residue peptide 2 favours a helical
conformation, resulting in the characterization of a long cylin-
drical helix in crystals. The overwhelming crystallinity of
hydrophobic helical peptide suggests that packing of apolar
cylinders into crystalline lattices must be highly favourable. The
extent to which the energetics of crystal packing promote the
selection of helical conformations in peptide single crystals
remains to be established. The present study reaffirms the
necessity of interrupting intramolecular hydrogen bonding
patterns in order to achieve helix termination in the middle of
long hydrophobic sequences.
Acknowledgements
This research was supported by the Department of Science and
Technology, Government of India. R. K. was supported by a
Research Associateship of the Department of Biotechnology,
Government of India.
References
1 I. L. Karle and P. Balaram, Biochemistry, 1990, 29, 6747.
2 P. Balaram, Curr. Opin. Struct. Biol., 1992, 2, 845.
Fig. 6 Superposition of the structure of the 14-residue peptide
(peptide 2) and the decapeptide Boc-Gly-Dpg-Gly-Val-Ala-Leu-Aib-
Val-Ala-Leu-OMe.27 The former is indicated by the solid line, while the
latter is represented by a broken line.
1664 J. Chem. Soc., Perkin Trans. 2, 1997
3 I. L. Karle, J. L. Flippen-Anderson, R. Gurunath and P. Balaram,
Protein Sci., 1994, 4, 1547.
4 A. Banerjee, S. Datta, A. Pramanik, N. Shamala and P. Balaram,
J. Am. Chem. Soc., 1996, 118, 9477.
5 I. L. Karle, R. B. Rao, S. Prasad, R. Kaul and P. Balaram, J. Am.
Chem. Soc., 1994, 116, 10 355.
6 I. L. Karle, R. Gurunath, S. Prasad, R. Kaul, R. B. Rao and
P. Balaram, J. Am. Chem. Soc., 1995, 117, 9632.
7 P. Balaram, Pure Appl. Chem., 1992, 64, 1061.
8 J. A. Bryant, C. B. Knobler and D. J. Cram, J. Am. Chem. Soc., 1990,
112, 1254.
9 J. A. Bryant, J. L. Ericson and D. J. Cram, J. Am. Chem. Soc., 1990,
112, 1254.
10 G. M. Whitesides, E. E. Simanek, J. P. Mathias, C. T. Seto,
D. N. Chin, M. Mammen and D. M. Gordon, Acc. Chem. Res.,
1995, 28, 37.
11 K. Uma, I. L. Karle and P. Balaram, in Proteins: Structure
Dynamics and Design, eds. V. Renugopalakrishnan, P. R. Carey,
I. C. P. Smith, S. G. Huang and A. Storer, ESCOM Science
Publishers B. V., Leiden, 1991.
12 R. Gurunath and P. Balaram, Biochem. Biophys. Res. Commun.,
1994, 202, 241.
13 I. L. Karle, J. L. Flippen-Anderson, M. Sukumar, K. Uma and
P. Balaram, J. Am. Chem. Soc., 1991, 113, 3952.
14 E. Benedetti, C. Toniolo, P. M. Hardy, V. Barone, A. Bavoso,
B. DiBlasio, P. Grimaldi, F. Lelj, V. Pavone, C. Pedone, G. M.
Bonora and I. Lingham, J. Am. Chem. Soc., 1984, 106, 8146.
15 V. Barone, F. Lelj, A. Bavoso, B. Di Blasio, P. Grimaldi, V. Pavone
and C. Pedone, Biopolymers, 1985, 24, 1759.
16 G. M. Bonora, C. Toniolo, B. Di Blasio, V. Pavone, C. Pedone,
E. Benedetti, I. Lingham and P. Hardy, J. Am. Chem. Soc., 1984,
106, 8152.
17 C. Toniolo, G. M. Bonora, A. Bavoso, E. Benedetti, B. Di Blasio,
V. Pavone, C. Pedone, V. Barone, F. Lelj, M. T. Leplawy,
K. Kaezmarek and A. Redlinski, Biopolymers, 1988, 27, 373.
18 B. Di Blasio, V. Pavone, C. Isernia, C. Pedone, E. Benedetti,
C. Toniolo, P. M. Hardy and I. Lingham, J. Chem. Soc., Perkin
Trans. 2, 1992, 523.
19 S. Prasad, R. B. Rao and P. Balaram, Biopolymers, 1995, 35, 11.
20 J. Karle and I. L. Karle, Acta Crystallogr., 1966, 21, 849.
21 E. Egert and G. M. Sheldrick, Acta Crystallogr., Sect. A., 1988, 41,
262.
22 J. Karle, Acta Crystallogr., 1968, 24, 182.
23 I. L. Karle, J. L. Flippen-Anderson, K. Uma and P. Balaram, Int. J.
Peptide Protein Res., 1988, 32, 536.
24 S. Datta, N. Shamala, A. Banerjee and P. Balaram, Int. J. Peptide
Protein Res., in press.
25 E. N. Baker and R. E. Hubbard, Progr. Biophys. Mol. Biol., 1984,
44, 97.
26 I. L. Karle, J. L. Flippen-Anderson, K. Uma and P. Balaram,
Biopolymers, 1990, 29, 1835.
27 I. L. Karle, R. B. Rao, R. Kaul, S. Prasad and P. Balaram,
Biopolymers, 1996, 39, 75.
28 I. L. Karle, R. Kaul, R. B. Rao, S. Raghothama and P. Balaram,
submitted for publication in J. Am. Chem. Soc.
29 IUPAC-IUB Commission on Biochemical Nomenclature, Eur. J.
Biochem., 1970, 17, 193.
Paper 7/02109G
Received 26th March 1997
Accepted 29th May 1997
